Cargando…

In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface

Hepatitis C virus (HCV) entry is dependent on host cell molecules tetraspanin CD81, scavenger receptor BI and tight junction proteins claudin-1 and occludin. We previously reported a role for CD81/claudin-1 receptor complexes in HCV entry; however, the molecular mechanism(s) driving association betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Christopher, Harris, Helen J, Hu, Ke, Drummer, Heidi E, McKeating, Jane A, Mullins, Jonathan G L, Balfe, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549482/
https://www.ncbi.nlm.nih.gov/pubmed/22897233
http://dx.doi.org/10.1111/cmi.12008
_version_ 1782256428383207424
author Davis, Christopher
Harris, Helen J
Hu, Ke
Drummer, Heidi E
McKeating, Jane A
Mullins, Jonathan G L
Balfe, Peter
author_facet Davis, Christopher
Harris, Helen J
Hu, Ke
Drummer, Heidi E
McKeating, Jane A
Mullins, Jonathan G L
Balfe, Peter
author_sort Davis, Christopher
collection PubMed
description Hepatitis C virus (HCV) entry is dependent on host cell molecules tetraspanin CD81, scavenger receptor BI and tight junction proteins claudin-1 and occludin. We previously reported a role for CD81/claudin-1 receptor complexes in HCV entry; however, the molecular mechanism(s) driving association between the receptors is unknown. We explored the molecular interface between CD81 and claudin-1 using a combination of bioinformatic sequence-based modelling, site-directed mutagenesis and Fluorescent Resonance Energy Transfer (FRET) imaging methodologies. Structural modelling predicts the first extracellular loop of claudin-1 to have a flexible beta conformation and identifies a motif between amino acids 62–66 that interacts with CD81 residues T149, E152 and T153. FRET studies confirm a role for these CD81 residues in claudin-1 association and HCV infection. Importantly, mutation of these CD81 residues has minimal impact on protein conformation or HCVglycoprotein binding, highlighting a new functional domain of CD81 that is essential for virus entry.
format Online
Article
Text
id pubmed-3549482
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-35494822013-01-22 In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface Davis, Christopher Harris, Helen J Hu, Ke Drummer, Heidi E McKeating, Jane A Mullins, Jonathan G L Balfe, Peter Cell Microbiol Original Articles Hepatitis C virus (HCV) entry is dependent on host cell molecules tetraspanin CD81, scavenger receptor BI and tight junction proteins claudin-1 and occludin. We previously reported a role for CD81/claudin-1 receptor complexes in HCV entry; however, the molecular mechanism(s) driving association between the receptors is unknown. We explored the molecular interface between CD81 and claudin-1 using a combination of bioinformatic sequence-based modelling, site-directed mutagenesis and Fluorescent Resonance Energy Transfer (FRET) imaging methodologies. Structural modelling predicts the first extracellular loop of claudin-1 to have a flexible beta conformation and identifies a motif between amino acids 62–66 that interacts with CD81 residues T149, E152 and T153. FRET studies confirm a role for these CD81 residues in claudin-1 association and HCV infection. Importantly, mutation of these CD81 residues has minimal impact on protein conformation or HCVglycoprotein binding, highlighting a new functional domain of CD81 that is essential for virus entry. Blackwell Publishing Ltd 2012-12 2012-09-25 /pmc/articles/PMC3549482/ /pubmed/22897233 http://dx.doi.org/10.1111/cmi.12008 Text en Copyright © 2012 Blackwell Publishing Ltd http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.
spellingShingle Original Articles
Davis, Christopher
Harris, Helen J
Hu, Ke
Drummer, Heidi E
McKeating, Jane A
Mullins, Jonathan G L
Balfe, Peter
In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface
title In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface
title_full In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface
title_fullStr In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface
title_full_unstemmed In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface
title_short In silico directed mutagenesis identifies the CD81/claudin-1 hepatitis C virus receptor interface
title_sort in silico directed mutagenesis identifies the cd81/claudin-1 hepatitis c virus receptor interface
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549482/
https://www.ncbi.nlm.nih.gov/pubmed/22897233
http://dx.doi.org/10.1111/cmi.12008
work_keys_str_mv AT davischristopher insilicodirectedmutagenesisidentifiesthecd81claudin1hepatitiscvirusreceptorinterface
AT harrishelenj insilicodirectedmutagenesisidentifiesthecd81claudin1hepatitiscvirusreceptorinterface
AT huke insilicodirectedmutagenesisidentifiesthecd81claudin1hepatitiscvirusreceptorinterface
AT drummerheidie insilicodirectedmutagenesisidentifiesthecd81claudin1hepatitiscvirusreceptorinterface
AT mckeatingjanea insilicodirectedmutagenesisidentifiesthecd81claudin1hepatitiscvirusreceptorinterface
AT mullinsjonathangl insilicodirectedmutagenesisidentifiesthecd81claudin1hepatitiscvirusreceptorinterface
AT balfepeter insilicodirectedmutagenesisidentifiesthecd81claudin1hepatitiscvirusreceptorinterface